The HemOnc Pulse Live at ASH: Phillip Scheinberg, MD, on CHIP, MDS Classification Updates

By Chadi Nabhan, MD, MBA, FACP, Phillip Scheinberg, MD - Last Updated: December 13, 2022

Phillip Scheinberg, MD, talks about developments in research and treatment for myelodysplastic syndromes (MDS) with Chadi Nabhan, MD, MBA, FACP, host of The HemOnc Pulse, during the 2022 American Society of Hematology Annual Meeting. Dr. Scheinberg and Dr. Nabhan discussed MDS classification updates, clonal hematopoiesis of indeterminate potential, the evolution of MDS, and more.

Post Tags:MDS ASH 22
Editorial Board